Enzymatic O-methylation of aromatic hydroxyl groups is an important step in the metabolism of endogenous catecholamines as well as of many xenobiotics. Catechol-O-methyltransferase (COMT 1 , EC 2.1.1.6) plays a central role in the metabolic inactivation of catecholic neurotransmitters, such as dopamine, norepinephrine, and epinephrine. Catecholestrogens and neuroactive drugs possessing a catechol structure, such as L-3,4-dihydroxyphenylalanine (L-DOPA) are also O-methylated by COMT (Guldberg and Marsden, 1975; Männistö et al., 1992) . The latter is of particular importance since L-DOPA remains the principal drug used in the therapy of Parkinson's disease.
Selective inhibition of COMT reduces the level of O-methylation of L-DOPA to 3-O-methyl-L-DOPA and increases the amount of L-DOPA gaining access to the brain (Männistö et al., 1992; Bonifati and Meco, 1999) . This observation has prompted interest in the development of potent COMT inhibitors, to be used as adjuncts in L-DOPA therapy of Parkinson's disease 1990) .
COMT requires Mg 2ϩ ions for catalysis and uses the ubiquitous cofactor S-adenosyl-L-methionine (AdoMet) as the methyl donor. The catalytic mechanism of COMT has been extensively detailed on the basis of structural (Vidgren et al., 1994) and theoretical studies (Vidgren and Ovaska, 1997; Zheng and Bruice, 1997; Lau and Bruice, 1998; Kahn and Bruice, 2000; Kuhn and Kollman, 2000; Lautala et al., 2001) . Binding of the catechol moiety to the catalytic site positions one of the catechol hydroxyls in close proximity to the activated methylsulfonium group of AdoMet. The reaction involves the transfer of the methyl group from the cofactor to the proximal hydroxyl group, generating the corresponding mono-O-methylated catechol and Sadenosyl-L-homocysteine (Guldberg and Marsden, 1975) .
Nitro-substituted catechol derivatives are among the most potent COMT inhibitors. They possess the same binding motif as the catechol substrates, but the presence of the strong electron-withdrawing nitro function hinders their reactivity toward O-methylation (Bäck-ström et al., 1989; Borgulya et al., 1989) . 1-(3,4-Dihydroxy-5-nitrophenyl)-2-phenyl-ethanone (BIA 3-202; Fig. 1 ) is a recently developed nitrocatechol-type COMT inhibitor (Parada et al., 2001; , the potential benefits of which for the treatment of Parkinsonian patients are presently under clinical evaluation.
The complexes between several nitrocatechol inhibitors and the soluble form of rat COMT (S-COMT) have been studied by X-ray crystallography. The first crystal structure reported (Vidgren et al., 1994) shows the enzyme complexed with the inhibitor 3,5-dinitrocat- echol (3,5-DNC, also OR-486). Later on, the crystallization of the enzyme with another nitrocatechol-type inhibitor (OR-1840) was mentioned in the literature (Vidgren et al., 1999) , although no detailed description or atomic coordinates were made available. More recently, two other structures were finally disclosed, showing the rat S-COMT complexed with a new tight-binding nitrocatechol inhibitor (BIA 3-335) (Bonifácio et al., 2002 ) and a bisubstrate inhibitor (Lerner et al., 2001 ). In vitro, COMT catalyzes the mono-O-methylation of substituted catechol substrates at either the meta (3-O-methylation) or para (4-O-methylation) hydroxyl functions, relative to the substituent at C1 (Fig. 2) . The ratio of meta/para O-methylation varies with the nature of the catechol substituent and the experimental conditions (Männistö et al., 1992) However, in vivo, the regioselectivity of O-methylation of those substrates generally shifts toward much higher meta/para ratios, with lesser or null amount of the p-O-methylated products being formed (Daly et al., 1960; Frère and Verly, 1971) .
The nitrocatechol inhibitors, on the other hand, are only negligibly O-methylated, in spite of the fact that they interact with the catalytic site of COMT. Nevertheless, after administration of the nitrocatechol inhibitor tolcapone to human volunteers, small amounts of the m-O-methyltolcapone derivative are formed, which accumulates for several days in plasma (Da Prada et al., 1994; Dingemanse et al., 1996) . However, no detectable p-O-methyltolcapone is reported. The same qualitative results are obtained with the new nitrocatechol inhibitor BIA 3-202, with which only marginal O-methylation of the m-hydroxyl group is observed in the rat and human (P. Soares-da-Silva, unpublished data).
Explanation of the apparently different regioselectivities of Omethylation by COMT in vivo versus in vitro conditions poses an intriguing challenge that has not been solved to date. Moreover, the apparently exclusive in vivo m-O-methylation of BIA 3-202 (and tolcapone) cannot be explained through analysis of the crystal structures of the complexes between COMT and this class of inhibitors. By simple observation of the X-ray structures, it is clear that in every case the catechol hydroxyl group in position meta (relative to the C1 substituent) is always sterically inaccessible to the methylsulfonium group of AdoMet.
In the present work, we study the nature of the molecular interaction of BIA 3-202 with the active site of rat S-COMT and propose a plausible explanation for the apparent paradox of the regioselectivity of its O-methylation in vivo. A putative structural model of the enzyme-inhibitor complex is presented, and the implications for the design of new inhibitor molecules, as well as for the understanding of their metabolism via O-methylation are discussed.
Materials and Methods
Chemicals and Enzyme. BIA 3-202, the individual meta-O-(BIA 3-270) and para-O-(BIA 3-449) methylated derivatives , tolcapone and its derivatives m-O-methyltolcapone and p-O-methyltolcapone were synthesized in the Laboratory of Chemistry (BIAL, Mamede do Coronado, Portugal). The recombinant rat soluble COMT was produced in Escherichia coli and was purified as previously described (Bonifácio et al., 2001; Rodrigues et al., 2001 ).
Molecular Modeling. The structures of the catechol-type ligands were built and optimized at the PM3 semiempirical level with Spartan Pro v1.03 program (Wavefunction, Inc., Irvine, CA). The atomic coordinates of rat S-COMT were obtained from the Protein Data Bank (1vid.pdb), water molecules were deleted (except HOH400 coordinated to Mg 2ϩ ), and all hydrogens added to the protein. The catechol was docked with both hydroxyls protonated, and Lys144 was considered deprotonated. Unrestrained flexible-docking of the catechol ligands and the COMT active site was performed with the program GOLD v1.1 (Jones et al., 1995a (Jones et al., ,b, 1997b ) using a genetic algorithm optimizer. Default parameters were employed except that the torsion constants for rotation about the C.ar-N.pl3 and C.ar-C.2 bond types were increased to 12.0 kcal/mol to hinder unrealistic free rotations of the catechol-nitro and catechol-carbonyl bonds, respectively. For the genetic algorithm used in the conformation space exploration, a population of 100 individuals (conformations) was subjected to 5 mutational generations with a selection pressure of 1.1. All atoms at COMT molecular surface within a radius of 14.0 Å from the Mg 2ϩ ion were used as the target-binding site. Catechol coordination to the Mg 2ϩ ion is implicitly treated by GOLD as a special hydrogen bond, where the metal behaves as a hydrogen bond donor. Therefore, no constraints were used to force the catechol into the catalytic position. The fit of a given protein-ligand interaction configuration is evaluated by a scoring function, which includes the intramolecular torsion energy of the ligand and both the intermolecular van der Waals and hydrogen-bonding potentials. As with all genetic algorithm optimizers there is no way to ascertain that the global minimum energy solution is obtained, therefore 20 independent docking runs were performed for each ligand, starting from random configurations, and the twenty optimized structures were analyzed as an ensemble of alternative complexes.
Metabolic Studies: in Vitro O-Methylation. Methylation of BIA 3-202 and tolcapone was evaluated by incubating 10 M of the nitrocatechol compound with 1 M COMT in enzyme reaction mixture. The reaction was terminated with one volume 1% formic acid in acetonitrile. Reaction products were analyzed by LC-(AP-ESI)MS (HP 1100 Series, Agilent Technologies, Palo Alto, CA) with negative ion detection. The separation was performed on a Lichrospher 100 RP-18 column (LiChroCART 250 -3, 5 m, Merck, Darmstadt, Germany). The mobile phases used were A, water/formic acid 1% (v/v) and B, acetonitrile/formic acid 1% (v/v). The gradient conditions were at 0 to 3 min 50% A and 50% B; at 10 min 47% A and 53% B; at 10 to 11 min 47% A and 53% B; and at 15 min 40% A and 60% B. The flow rate was 0.8 ml/min, and injection volume was 30 l. Selected ion monitoring with detection set for the molecular ion of each compound of interest was used for quantification. The analytical range used extended from 20 to 500 ng/ml for the standards of meta-O-and para-O-methylated BIA 3-202 and tolcapone.
Metabolic Studies: Microsomal Metabolism. BIA 3-270, BIA 3-449, m-O-methyltolcapone, and p-O-methyltolcapone (100 M) were independently incubated with rat liver microsomes (prepared by differential centrifugation) containing 0.8 mg of total protein in 100 mM phosphate buffer, pH 7.4, 60 mM MgCl 2 as described elsewhere (Busse et al., 1995) . The reactions, started by the addition of 4 mg/ml NADPH, were carried out at 37°C and were terminated with one volume 1% formic acid in acetonitrile. Reaction products were analyzed by LC-(AP-ESI)-MS as described above. Control experiments were established by testing the same reactions in the absence of added drug or the microsomes.
Results
Molecular Interactions: Docking of BIA 3-202. The structure of the functional complex formed between BIA 3-202 and COMT was studied by unrestrained flexible-docking simulations. In addition, 3,5-dinitrocatechol and L-DOPA ( Fig. 1) were also independently docked to the active site of the enzyme to assess the performance of the docking procedure and its ability to predict experimental data. The docked configurations of 3,5-DNC were compared with that of the crystallographic complex (1vid.pdb) and those of L-DOPA used to explain the observed regioselectivity (meta/para-O-methylation ratio) of S-COMT with this catechol substrate.
In all 60-docked models generated (20 for each molecule), the catechol moiety is bound into the catalytic pocket of COMT, with the two catechol hydroxyl oxygens forming a bidentate chelate with the Mg 2ϩ ion (average Mg-O distances between 1.7 and 2.2 Å). Furthermore, the two hydroxyls are consistently found at hydrogen-bonding distances from the carboxylate of Glu199 and the ⑀-NH 2 of Lys144 (average donoracceptor distances of 2.6 and 3.0 Å, respectively). These results are already significant per se, if one considers the fact that the ligands were docked to a wide portion of COMT surface (28 Å diameter), without constraining them to form direct interactions with the catalytic site or the Mg 2ϩ ion. The results support earlier suggestions that the substrate (or inhibitor) recognition is primarily dependent on the presence of two adjacent hydroxyl groups bound to an aromatic ring (Vidgren et al., 1994; Lautala et al., 2001 ) and indicate that the docking algorithm is able to capture it.
Before proceeding into the presentation of further results, we shall define a set of notations to be used throughout the text. The hydroxyl oxygen situated in meta position relative to the substituent R1 (5-nitro function of 3,5-DNC or to the substituent group at C1 in L-DOPA or BIA 3-202), will be herein denominated mO. The other catechol hydroxyl will be denoted pO, independently of the particular nomenclature of each system (see Fig. 1 ).
Given the geometry of the active site, the catechol ring may adopt two alternative-docked orientations, related to each other by a 180-degree rotation about the catechol symmetry axis. In each pose, the Mg 2ϩ can coordinate both catechol hydroxyls, but only one of then may be sterically accessible to the methylsulfonium group of the co-substrate (see Fig. 2 ). Hence, these two binding modes will be denoted as meta or para, if the hydroxyl oxygen that is closer to AdoMet is mO or pO, respectively.
The results of all 20 independently optimized docked configurations of BIA 3-202 are summarized in Fig. 3 . This plot represents the distances between the transferable methyl carbon of AdoMet and each of the catechol hydroxyl oxygens -mO and pO -for every complex model generated. The plot thus emphasizes the meta versus para binding modes adopted. The first noticeable observation is that populations of the two classes of complexes may compete in solution. These are related to each other by a 180-degree rotation about the dmd.aspetjournals.org catechol symmetry axis, showing that the nitro group can be accommodated in either side of the binding pocket. This result contrasts with the well defined and reproducible bound configuration found in the X-ray structures of related nitrocatechol inhibitors, co-crystallized with COMT. Moreover, the diversity of interaction poses indicated for BIA 3-202 also diverges from the single highly preferential binding mode predicted for 3,5-dinitrocatechol or L-DOPA, as will be discussed below.
After clustering docked structures that are similar to each other (a threshold of 0.55 Å in root-mean square deviation was used), three distinct families of interaction modes were obtained. The solution structure possessing the highest interaction score within each family is shown in Fig. 4 .
The two top scoring structures (Fig. 4 , panels A and B) present similar interaction scores (56.1 and 54.9 GOLD internal units) and the positions of the nitrocatechol ring are nearly identical in both and close to that of the crystallographic 3,5-DNC. The inhibitor binds to the catalytic site in para orientation, with the two catechol hydroxyls coordinating the Mg 2ϩ ion and pO in the vicinity of the methylsulfonium of AdoMet (average distance of 2.7 Å). The nitro group fits tightly at one end of the binding pocket, forming favorable van der Waals interactions with the indole ring of Trp143. One of the oxygen atoms of the nitro group is completely buried by the protein and is near the ⑀-amino group of Lys144, whereas the other oxygen is partially solvated. Moreover, the mO and pO hydroxyl oxygens are within hydrogen-bonding distances from the side chain terminal oxygen and nitrogen atoms of Glu199 (1.7 Å) and Lys144 (2.1 Å), respectively. The two solution structures differ from each other, however, in the conformations and interactions adopted by the 1-(2-phenyl-ethanone) side chain. In model A, the phenyl ring fits into the highly hydrophobic environment created by Leu198, Trp38 and Pro174, to which it forms favorable van der Waals contacts (Fig. 4,  panel A) . The oxygen atom of the carbonyl group, on the other hand, rests approximately in the plane of the catechol ring and is accessible to the solvent, thus contributing favorably to a decrease in the energy cost of desolvation.
In model B, the carbonyl group is flipped 180-degrees toward Leu198 and is desolvated. The phenyl ring, on the other hand, bends toward one side of the catechol and stacks onto the aromatic ring of Trp38, making extensive aromatic interactions (Fig. 4, panel B) .
It should be pointed out that the interaction scoring function implemented in GOLD does not include explicit solvation terms, and so this effect may be underestimated in the present simulations. Therefore, despite the similar interaction scores, model A might represent an energetically preferable interaction mode, because of the fact that the carbonyl oxygen of the ligand remains solvated in the bound form.
The third predicted bound conformation of BIA 3-202 (model C), however, adopts a meta orientation with respect to the binding mode of the nitrocatechol moiety. The two catechol hydroxyls are still coordinated to the Mg 2ϩ ion, but the hydroxyl mO is now near (2.9 Å) the methylsulfonium of AdoMet. The nitro group forms van der Waals contacts to Leu198, at the opposite end of the binding pocket. The interaction score of this solution structure is relatively lower (49.8 GOLD internal units) than those of the previous two, as can be seen in Fig. 3 . The analysis of the energy components reveals that the main factors contributing to the lower score are the steric impediments of the nitro group in the tighter side of the pocket, near Leu198. The repulsive potentials because of atomic overlaps force the catechol ring to tilt approximately 20 degrees in the plane of the ring (relative to the coordinates of the crystallographic 3,5-DNC) and to adopt a slightly 
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In every docked model, the carbonyl group tends to adopt a planar conformation in relation to the catechol aromatic ring. This conjugated system is also expected to be planar for free BIA 3-202 in solution. As a consequence, the inhibitor should bind into the narrow catalytic pocket of COMT with little loss of conformational entropy, thus contributing to its high affinity. This is thought to be a characteristic relevant to BIA 3-202 and generally to other COMT ligands (Lautala et al., 2001) .
Validation. As mentioned above, the COMT inhibitor 3,5-dinitrocatechol and the substrate L-DOPA were also docked to the enzyme under the same conditions as for BIA 3-202, to assess the validity of the docking procedure. These two compounds were chosen since they are structurally related to BIA 3-202, and there is sufficient structural and functional information available to which the results of the simulation could be correlated.
All 20-independent docking runs with 3,5-DNC predicted virtually identical binding configurations, also similar to that of the X-ray structure (average root-mean square deviation of 0.45 Å, nonhydrogen atoms). All essential interactions between the inhibitor and the protein residues are reproduced, the only difference being a shortening of the Mg-O bond lengths by about 0.25 Å (Fig. 5) .
The overall docked solutions are also described in Fig. 6A , with emphasis given to the distances between the carbon of methylsulfonium from AdoMet and each of the two catechol hydroxyl oxygens (mO and pO). Docking of 3,5-DNC to COMT consistently predicts binding in the para orientation, in which the pO is positioned within 2.5-3.0 Å from the methyl group of AdoMet. These values compare well to the 2.6 Å found in the cocrystallized structure (1vid.pdb).
In contrast to 3,5-DNC, L-DOPA shows a clear preference for binding in the opposite orientation (meta), with the pO hydroxyl positioned away from AdoMet and mO at an average distance of 2.8 Å from the positively charged methylsulfonium of the cosubstrate (Fig. 6B) . These results suggest a preferential O-methylation of L-DOPA at position meta, which thoroughly agrees with the observed meta/para-O-methylation ratio of 20.3 (about 95% methylation at position mO) with S-COMT (Lotta et al., 1995) . The results obtained with 3,5-dinitrocatechol and L-DOPA establish a validation support for the docking procedure with COMT and substituted catechol ligands.
Metabolic Studies: in Vitro O-Methylation and O-Demethylation. To verify the hypothesis raised by the docking simulations, we investigated whether BIA 3-202 could, in fact, undergo in vitro enzymatic O-methylation at both pO and mO positions (see Fig. 1 ). Nitrocatechols are known to be extremely poor substrates of COMT, even though they bind to the catalytic site. However, after incubation of 1.0 M purified recombinant rat COMT (soluble form) with an excess of BIA 3-202 (10 M), small amounts of both m-O-(BIA 3-270) and p-O-(BIA 3-449) methylated products were formed in a time-dependent fashion (Fig. 7A) . Control experiments with no enzyme added revealed no traces of the methylated products.
Irrespective of the efficiency of the enzymatically catalyzed Omethylation reaction, these experimental results show that approximately equivalent levels of m-O-and p-O-methylated products are formed, indicating a low regioselectivity of the enzyme toward this compound. Moreover, the above results clearly show that, in solution, BIA 3-202 is concurrently binding to the catalytic site in the two alternative configurations, leading to both meta-and para-O- The two hydroxyl groups of the catechol moiety are coordinated to the Mg 2ϩ ion and form hydrogen bonds to Glu199 and Lys144. Amine nitrogens and carboxylic oxygens are represented in dark blue and red, respectively. Solution structures A and B represent binding in para orientation whereas in solution C the inhibitor binds in the meta configuration. However, the fact that no traces of BIA 3-449 are found in the plasma of humans or rats given large doses of BIA 3-202 prompted the search for additional in vivo metabolic routes. O-demethylation of methoxy-catecholamines has long been proposed to play a role in the in vivo metabolism of catecholamines (Daly et al., 1960; Frère, 1971; Frère and Verly, 1971) . In particular, different families of cytochromes P450 have been shown to catalyze the O-demethylation of several methoxy-phenol and methoxy-catechol types of substrates in rat and human liver microsomes (Busse et al., 1995; Rodrigues, et al., 1996; Jones, et al., 1997a; Roser and Thomas, 2000; Uckun et al., 2002) .
To investigate the possible enzymatic O-demethylation of BIA 3-449 and BIA 3-270, these were independently incubated with rat liver microsomes and NADPH. The samples were monitored for the formation of BIA 3-202. Figure 7B shows that rat liver microsomes are capable of O-demethylating BIA 3-449, converting it back to BIA 3-202. Moreover, this reaction appears to be regioselective since the para-O-methylated compound (BIA 3-449) is converted to BIA 3-202 about 4.6 times faster than its meta regioisomer (BIA 3-270). However, O-demethylation is far from being the only metabolic route accounting for the degradation of BIA 3-449. During the first 60 min of incubation, the concentration of the para-O-methylated compound decreases about 40%, whereas only a small fraction of its disappearance may be attributed to O-demethylation (data not shown). On the other hand, no significant disappearance of BIA 3-270 is observed after 60 min of incubation with the microsomes.
We have also studied, for comparison, the metabolism of the related compound tolcapone, concerning its O-methylation and Odemethylation reactions. All experiments were performed under the same conditions as described above. Figure 8A shows that tolcapone undergoes mono-O-methylation at either meta or para hydroxyls by the recombinant rat S-COMT in vitro. However, in this case, the meta/para ratio is about 1:2.
When incubated with rat liver microsomes, para-O-methyltolcapone was almost completely metabolized after 60 min, whereas no depletion of meta-O-methyltolcapone was registered (data not shown). No attempts have been made to follow the complete metabolic reactions of O-methyltolcapone, except for the microsomal O-demethylation. Figure 8B reveals that the p-O-methylated derivative is selectively converted into tolcapone, whereas no Odemethylation of meta-O-methyltolcapone could be detected (Fig.  8B) . It can be seen that, after an initial period of increasing accumulation of tolcapone, its concentration starts decaying. This is probably because of further metabolism of the drug by microsomal enzymes, which also contributes to the depletion of the p-O-methyltolcapone metabolite. The m-O-methyltolcapone, on the other hand, appears not 
FIG. 6. Docking results of 3,5-DNC (A) and L-DOPA (B).
In each panel, 20 independently optimized docked structures are represented in decreasing order of their interaction scores (dashed line). The distances between the methylsulfonium carbon (CE) of AdoMet and the catechol pO (F) and mO (E) are shown for each solution structure.
MOLECULAR INTERACTIONS AND METABOLISM OF A COMT INHIBITOR
at ASPET Journals on October 14, 2017 dmd.aspetjournals.org Downloaded from to be metabolized by the microsomal enzymes and remains present after 60 min.
Discussion
The observed conversion of BIA 3-202 (P. Soares-da-Silva, unpublished data) or tolcapone (Da Prada et al., 1994; Dingemanse et al., 1996) into the respective m-O-methylated (but not the p-O-methylated) products, in the plasma of humans and rats, constitutes an intriguing paradox with respect to the pool of crystallographic information available. In all X-ray structures of complexes between COMT and related nitrocatechol inhibitors that have been reported (Vidgren et al., 1994 (Vidgren et al., , 1999 Lerner et al., 2001; Bonifácio et al., 2002) , the meta-hydroxyl oxygen of the nitrocatechol motif is sterically inaccessible to the methylsulfonium group of AdoMet. Therefore, the available crystallographic data may not be strictly extended to the case of BIA 3-202 (or tolcapone). Instead, alternative modes of binding between the inhibitor and the catalytic site of the enzyme must occur in solution. In this work, the molecular basis of the interaction of BIA 3-202 with catechol-O-methyltransferase was characterized by molecular modeling and in vitro enzymatic experiments.
The unrestrained flexible-docking simulations, herein presented, predict that BIA 3-202 interacts competitively to the substrate of the enzyme, as is generally reported for the nitrocatechol COMT inhibitors (Vidgren and Ovaska, 1997) . According to the obtained models, the enzyme-inhibitor complex is stabilized by the coordination bonds formed between the two catechol hydroxyl oxygens and the Mg 2ϩ ion and by hydrogen bonds between the same hydroxyls and the residues Glu199 and Lys144. In addition, extensive van der Waals contacts also contribute to the stabilization of the complex. The benzyl carbonyl group of the 1-(2-phenyl-ethanone) substituent may have an important role in binding thermodynamics, as indicated by the dramatic decrease in potency of the inhibitor upon replacement of the carbonyl group (CO) by methylene (CH 2 ) . Our docking results suggest that this group may have a 2-fold role in the stabilization of the complex. On one hand it may contribute to reducing the desolvation free energy penalty upon formation of the complex. On the other hand, fitting into the narrow catalytic site forces the substituent atoms attached to the catechol C1 to remain in the same plane of the catechol ring. Since the carbonyl group and the catechol aromatic ring tend to be coplanar in solution because of conjugation of the respective systems, the association process is expected to proceed with minimal loss of conformational entropy. This is thought to be a relevant characteristic of BIA 3-202. Interestingly, catechol substrates with a planar conjugated substituent or a FIG. 7. A,  fused unsaturated ring meta to the hydroxyl group, such as 3,4-dihydroxybenzoic acid ethyl ester, caffeic acid, or 6,7-dihydroxycoumarin show higher affinity for COMT than equivalent nonconjugated compounds (Lautala et al., 2001) . Finally, inspection of the catalytic site clearly shows that when the nitrocatechol motif is bound to the catalytic site, only one of the catechol hydroxyls is sterically accessible to the methylsulfonium of AdoMet.
Regarding the multiple possibilities of interaction, the solution structure of the complex between COMT and BIA 3-202 is better described as an ensemble of alternative bound configurations, rather than one unique form. The two main predicted bound configurations -meta and para -are related to each other by a 180-degree rotation about the catechol symmetry axis and force either pO or mO hydroxylates, respectively, into catalytically competent positions. The implication of this conclusion is that, if there is any O-methylation of BIA 3-202, it should be able to occur at either meta or para hydroxyl oxygens.
Indeed, our in vitro experiments showed that in the presence of an excess of BIA 3-202, the recombinant enzyme could catalyze the formation of small but equivalent quantities of both p-O-and m-Omethylated derivatives. These results constitute direct evidence that the inhibitor must be able to bind in at least two alternative orientations that enable the formation of the two possible O-methylated products.
The reasons why the in vivo metabolism of BIA 3-202 (P. Soaresda-Silva, unpublished data) or tolcapone (Da Prada et al., 1994; Dingemanse et al., 1996) leads to the accumulation of their respective m-O-methylated but not the p-O-methylated products remains an open question. However, the results of this work indicate that p-O-methylated derivatives of both inhibitors are subjected to further microsomal metabolism, whereas no significant conversion is observed with the respective meta-isomers. Whereas the major conversion routes undertaken by the methylated compounds are still to be disclosed, we have shown that at least part of the disappearance of p-O-methylated BIA 3-202 and p-O-methyltolcapone is because of their O-demethylation, catalyzed by a microsomal enzyme system. Moreover, this demethylation is shown to be regioselective toward the para-methylated metabolites. Indeed, regioselective O-demethylation of compounds possessing single or conjugated aromatic rings with adjacent methoxy groups has been previously reported. Such is the case of the calcium channel blocker verapamil, which possesses a 3,4-dimethoxyphenyl motif and is shown to be selectively O-demethylated at the para position by a cytochrome P450 of the 2C subfamily (Busse et al., 1995) . Furthermore, other para-substituted methoxyphenyl compounds also undergo O-demethylation by different cytochromes P450 isoforms (Jones et al., 1997a; Kuriya et al., 2000) .
It is proposed therefore that BIA 3-202 may in fact undergo in vivo O-methylation by COMT at either meta or para catechol hydroxyl groups but that subsequent metabolic routes would lead to preferential reutilization of the p-O-methylated derivative (BIA 3-449). The overall balance is the observed accumulation of the m-O-methylated metabolite (BIA 3-270) over the para-isomer. A similar mechanism is suggested for the related COMT inhibitor, tolcapone.
Additional details of the docking experiments are discussed in the following paragraphs. The validity of the theoretical approach was assessed by performing additional docking experiments between 3,5-DNC or L-DOPA and COMT. The crystallographic structure of the complex COMT/3,5-DNC is correctly predicted, as is the regioselectivity of O-methylation of L-DOPA by the enzyme.
The comparison of the docking results of BIA 3-202 with those of 3,5-dinitrocatechol provide some insights into the reasons for the different preferences of meta/para binding modes of the two ligands.
We have shown that the nitrocatechol motif is able to adopt two opposite orientations in the catalytic pocket. Preliminary docking simulations with 3-nitrocatechol (data not shown) indicate, however, that the nitro group itself has a clear tendency to dock exclusively on the side of the AdoMet cosubstrate (corresponding to para geometry). The same behavior is predicted herein for the related 3,5-DNC. Hence, the additional nitro group at position C5 (see Fig. 1 ) does not appear to counteract that preference. Indeed, it stacks well between the two hydrophobic residues Trp38 and Pro174, maximizing van der Waals contacts (Fig. 5) . The 1-(2-phenyl-ethanone) substituent of BIA 3-202 has a different effect, although. Being larger and more flexible than the nitro group, the 1-(2-phenyl-ethanone) substituent is able to explore additional favorable interactions with neighboring residues. Such is the case illustrated in Fig. 4C , where extensive hydrophobic interactions between the phenyl side chain of the inhibitor and the indole ring of Trp143 apparently overcomes the steric constraints resulting from binding the nitrocatechol moiety in meta configuration. This means that the 5-nitro and the 1-(2-phenyl-ethanone) substituents of BIA 3-202 must compete with each other to drive the formation of the complex in either para or meta orientation, respectively. The observed overall result of such competition is a mixture of the two binding configurations.
Despite the efforts undertaken to co-crystallize COMT with BIA 3-202, no crystals have been obtained. Naturally, the coexistence of multiple forms of the complex is one possible explanation for the lack of success in the co-crystallization. It should be noted, on the other hand, that the inhibitor 3,5-DNC, the bound structure of which has been determined by X-ray, is predicted by our approach to have only one highly preferential binding mode.
With regard to the regioselectivity of COMT with its natural substrates, the polar substituents (R) have been shown to generally favor O-methylation of catechols at meta rather than para position relative to R (Creveling et al., 1972; Lotta et al., 1995) .
Previous molecular dynamics studies have suggested that ionized carboxylic or amine groups would guide the catechol substituent into the meta position (relative to the methylation site), to avoid unfavorable electrostatic interactions with active site hydrophobic residues (Lotta et al., 1995; Lau and Bruice, 1998; Kuhn and Kollman, 2000) . Although electrostatics typically play an important role in molecular interactions, it is interesting to note that in the case of L-DOPA, the regioselectivity can be adequately explained with the present results, without taking into account explicit electrostatic terms. In GOLD scoring function, van der Waals and hydrogen-bonding potentials are the only intermolecular terms used to guide the structure optimization.
The binding pocket of COMT if flanked, on one side (opposite to the methylation site), by the two hydrophobic and bulky residues Trp38, Pro174, and Leu198, which increase locally the height of the cavity and narrow the entrance space. As a consequence, the amine and carboxylic groups attached to the sp 3 ␣-carbon of L-DOPA can hardly fit between those three residues and tend to direct the catechol substituent into the opposite direction (against Trp143), where the ionized groups become extensively solvated. Such steric constraints contribute to populate catechol binding-modes that favor O-methylation at position meta (mO). Hence, the current results, although strictly qualitative, suggest an alternative explanation for the observed COMT regioselectivity with L-DOPA.
In general terms, the information herein presented provides evidence of the role of molecular modeling as complimentary tools to classical experimental techniques. In particular, the current findings are expected to provide important insights for the design of new COMT inhibitors and for better understanding their metabolism by COMT. Despite the obvious similarities between the core structure of
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at ASPET Journals on October 14, 2017 dmd.aspetjournals.org BIA 3-202 and that of other nitrocatechol inhibitors already cocrystallized with COMT, the actual solution structures of these complexes may be much more diverse than those that have been provided by X-ray crystallography. This knowledge could expand the possibilities of exploring additional intermolecular interactions between COMT and new inhibitors.
